US Bancorp’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744 Hold
81
﹤0.01% 4016
2026
Q1
$833 Hold
81
﹤0.01% 3960
2025
Q4
$613 Hold
81
﹤0.01% 3907
2025
Q3
$335 Sell
81
-1
-1% -$4 ﹤0.01% 3905
2025
Q2
$246 Hold
82
﹤0.01% 4059
2025
Q1
$232 Hold
82
﹤0.01% 4087
2024
Q4
$478 Hold
82
﹤0.01% 4027
2024
Q3
$363 Hold
82
﹤0.01% 3976
2024
Q2
$2.16K Hold
82
﹤0.01% 3708
2024
Q1
$2.23K Buy
+82
New +$2.6K ﹤0.01% 3709
2022
Q2
Sell
-35
Closed -$5K 4070
2022
Q1
$5K Sell
35
-103
-75% -$10.9K ﹤0.01% 3589
2021
Q4
$18K Buy
138
+35
+34% +$4.43K ﹤0.01% 3154
2021
Q3
$10K Buy
+103
New +$10.5K ﹤0.01% 3420

Other funds holding LONA

US Bancorp's LONA Position: Q2 2026 in Review

US Bancorp held its LeonaBio Inc (LONA) position steady in Q2 2026 at 81 shares worth $744. The position accounts for ﹤0.01% of the portfolio, ranked #4016.

US Bancorp first reported a position in LONA in Q3 2021 and has held it in 13 quarters since. The position peaked at $18K in Q4 2021. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • US Bancorp held 81 shares of LeonaBio Inc worth $744 as of Q2 2026.
  • US Bancorp left its LeonaBio Inc share count unchanged in Q2 2026.
  • LeonaBio Inc made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4016 holding.
  • US Bancorp first reported a position in LeonaBio Inc in Q3 2021 and has held it in 13 quarters since.
  • US Bancorp's LeonaBio Inc position peaked at $18K in Q4 2021.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.